You are here
Clinical Trials: Eye Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Retinitis Pigmentosa
Intervention: Biological: Intravitreal autologous CD34+ cells
Sponsors: University of California, Davis; Cures Within Reach
Recruiting
Intervention: Biological: Intravitreal autologous CD34+ cells
Sponsors: University of California, Davis; Cures Within Reach
Recruiting
Conditions: Ciliopathies; Nephronophthisis; Senior-Loken Syndrome; Joubert Syndrome; Jeune Syndrome; Bardet-Biedl Syndrome
Interventions: Other: Blood sample; Other: Urine sample
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Interventions: Other: Blood sample; Other: Urine sample
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Condition: Retinitis Pigmentosa (RP)
Interventions: Biological: Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa; Biological: Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa
Sponsors: Jinnah Burn and Reconstructive Surgery Centre, Lahore; The Layton Rahmatullah Benevolent Trust (LRBT) Free Eye Hospital, Township Lahore.; Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore.
Recruiting
Interventions: Biological: Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa; Biological: Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa
Sponsors: Jinnah Burn and Reconstructive Surgery Centre, Lahore; The Layton Rahmatullah Benevolent Trust (LRBT) Free Eye Hospital, Township Lahore.; Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore.
Recruiting
Condition: Retinitis Pigmentosa
Intervention: Biological: human retinal progenitor cells
Sponsors: jCyte, Inc; California Institute for Regenerative Medicine (CIRM)
Not yet recruiting
Intervention: Biological: human retinal progenitor cells
Sponsors: jCyte, Inc; California Institute for Regenerative Medicine (CIRM)
Not yet recruiting
Condition: Glaucoma
Interventions: Drug: NT-501; Other: Sham comparator
Sponsor: Stanford University
Not yet recruiting
Interventions: Drug: NT-501; Other: Sham comparator
Sponsor: Stanford University
Not yet recruiting
Condition: Age-Related Macular Degeneration
Intervention: Combination Product: iPSC-derived RPE/PLGA transplantation
Sponsor: National Eye Institute (NEI)
Recruiting
Intervention: Combination Product: iPSC-derived RPE/PLGA transplantation
Sponsor: National Eye Institute (NEI)
Recruiting
Condition: Retinitis Pigmentosa
Intervention: Biological: CNS10-NPC implantation
Sponsors: Cedars-Sinai Medical Center; California Institute for Regenerative Medicine (CIRM)
Recruiting
Intervention: Biological: CNS10-NPC implantation
Sponsors: Cedars-Sinai Medical Center; California Institute for Regenerative Medicine (CIRM)
Recruiting
Condition: Dry Eye
Intervention: Drug: Umbilical Mesenchymal Stem Cells derived Exosomes
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Not yet recruiting
Intervention: Drug: Umbilical Mesenchymal Stem Cells derived Exosomes
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Not yet recruiting
Condition: Central Retinal Vein Occlusion
Interventions: Biological: Autologous Bone Marrow CD34+ Stem Cells; Biological: Sham Therapy
Sponsors: The Emmes Company, LLC; National Eye Institute (NEI); University of California, Davis
Not yet recruiting
Interventions: Biological: Autologous Bone Marrow CD34+ Stem Cells; Biological: Sham Therapy
Sponsors: The Emmes Company, LLC; National Eye Institute (NEI); University of California, Davis
Not yet recruiting
Condition: Retinitis Pigmentosa
Intervention: Biological: Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)
Sponsor: Centre d'Etude des Cellules Souches
Not yet recruiting
Intervention: Biological: Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)
Sponsor: Centre d'Etude des Cellules Souches
Not yet recruiting
